BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shendre A, Dillon C, Limdi NA. Pharmacogenetics of warfarin dosing in patients of African and European ancestry. Pharmacogenomics 2018;19:1357-71. [PMID: 30345882 DOI: 10.2217/pgs-2018-0146] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Shah-Williams E, Levy KD, Zang Y, Holmes AM, Stoughton C, Dexter P, Skaar TC. Enrollment of Diverse Populations in the INGENIOUS Pharmacogenetics Clinical Trial. Front Genet 2020;11:571. [PMID: 32670350 DOI: 10.3389/fgene.2020.00571] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wanounou M, Shaul C, Abu Ghosh Z, Alamia S, Caraco Y. The Impact of CYP2C9*11 Allelic Variant on the Pharmacokinetics of Phenytoin and (S)-Warfarin. Clin Pharmacol Ther 2022;112:156-63. [PMID: 35426132 DOI: 10.1002/cpt.2613] [Reference Citation Analysis]
3 Rollinson V, Turner R, Pirmohamed M. Pharmacogenomics for Primary Care: An Overview. Genes (Basel) 2020;11:E1337. [PMID: 33198260 DOI: 10.3390/genes11111337] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Youssef E, Kirkdale CL, Wright DJ, Guchelaar HJ, Thornley T. Estimating the potential impact of implementing pre-emptive pharmacogenetic testing in primary care across the UK. Br J Clin Pharmacol 2021;87:2907-25. [PMID: 33464647 DOI: 10.1111/bcp.14704] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Koshy L, Vb R, M M, Ben MP, Kishor P, Sudhakaran PR, Abdullakutty J, Venugopal K, Zachariah G, Mohanan PP, Harikrishnan S, G S. Pharmacogenetic variants influence vitamin K anticoagulant dosing in patients with mechanical prosthetic heart valves. Pharmacogenomics 2022. [PMID: 35608144 DOI: 10.2217/pgs-2022-0014] [Reference Citation Analysis]
6 Asiimwe IG, Pirmohamed M. Ethnic Diversity and Warfarin Pharmacogenomics. Front Pharmacol 2022;13:866058. [PMID: 35444556 DOI: 10.3389/fphar.2022.866058] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Vidović S, Škrbić R, Stojiljković MP, Vidović V, Bećarević J, Stoisavljević-Šatara S, Maksimović N. Prevalence of five pharmacologically most important CYP2C9 and CYP2C19 allelic variants in the population from the Republic of Srpska in Bosnia and Herzegovina. Arh Hig Rada Toksikol 2021;72:129-34. [PMID: 34187105 DOI: 10.2478/aiht-2021-72-3499] [Reference Citation Analysis]
8 Sabry S, El Wakeel LM, Saleh A, Ahmed MA. Comparison of Warfarin Initiation at 3 mg Versus 5 mg for Anticoagulation of Patients with Mechanical Mitral Valve Replacement Surgery: A Prospective Randomized Trial. Clin Drug Investig 2022. [PMID: 35274222 DOI: 10.1007/s40261-022-01137-7] [Reference Citation Analysis]
9 Asiimwe IG, Waitt C, Sekaggya-Wiltshire C, Hutchinson C, Okello E, Zhang EJ, Semakula JR, Mouton JP, Cohen K, Blockman M, Lamorde M, Jorgensen AL, Pirmohamed M. Developing and Validating a Clinical Warfarin Dose-Initiation Model for Black-African Patients in South Africa and Uganda. Clin Pharmacol Ther 2021;109:1564-74. [PMID: 33280090 DOI: 10.1002/cpt.2128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Davis BH, Williams K, Absher D, Korf B, Limdi NA. Evaluation of population-level pharmacogenetic actionability in Alabama. Clin Transl Sci 2021. [PMID: 34121327 DOI: 10.1111/cts.13097] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Chen H, Dai DP, Zhou S, Liu J, Wang SH, Wu HL, Zhou Q, Geng PW, Chong J, Lü Y, Cai JP, Yang JF. An identification and functional evaluation of a novel CYP2C9 variant CYP2C9*62. Chem Biol Interact 2020;327:109168. [PMID: 32531309 DOI: 10.1016/j.cbi.2020.109168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Shah RR. Genotype‐guided warfarin therapy: Still of only questionable value two decades on. J Clin Pharm Ther 2020;45:547-60. [DOI: 10.1111/jcpt.13127] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
13 Asiimwe IG, Zhang EJ, Osanlou R, Jorgensen AL, Pirmohamed M. Warfarin dosing algorithms: A systematic review. Br J Clin Pharmacol 2021;87:1717-29. [PMID: 33080066 DOI: 10.1111/bcp.14608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Qian M, Zhao H, Lou Y, Wang J, Wang S, Wang Z, Ou H, Li J, Yang F, Bai L, Lv H, Peng X, Chen X, Yang X. Establishment of prediction algorithm for the Honghe minority group based on warfarin maintenance dose. Pharmacogenomics 2022. [PMID: 35880564 DOI: 10.2217/pgs-2022-0038] [Reference Citation Analysis]
15 Grizzle WE. Issues in the Use of Human Tissues to Support Precision Medicine. J Health Care Poor Underserved 2019;30:66-78. [PMID: 31735720 DOI: 10.1353/hpu.2019.0117] [Reference Citation Analysis]